InvestorsHub Logo
Followers 34
Posts 3008
Boards Moderated 0
Alias Born 02/27/2016

Re: None

Sunday, 04/18/2021 10:53:41 AM

Sunday, April 18, 2021 10:53:41 AM

Post# of 462992
Michael K. - Australian Clinical & Scientific Lead at Anavex Life

Still wondering what this new hire is about - Poached from Hammond Care.

This would make sense if we were running all of our new trials in Australia. Fragile X, Parkinson’s imaging and the new indication. However I don’t believe Missling would want to pigeon hole us like that considering he hasn’t thus far.

So why an Austrialian focused clinical and scientific lead when all of the legwork for our current trials have been done already.

There’s no doubt an Australian expansion of some kind. It must be larger than the trials we’ve already done there because we didn’t need one before with 3 trials going on.

So what does this portend? A P4 or PA in PDD or Alz. What else could it be to need to hire a highly respected clinical lead?


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News